These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9869271)

  • 1. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor.
    Wakitani K; Nanayama T; Masaki M; Matsushita M
    Jpn J Pharmacol; 1998 Nov; 78(3):365-71. PubMed ID: 9869271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats.
    Niki H; Yamada M; Yamaki K; Mue S; Ohuchi K
    Eur J Pharmacol; 1998 Mar; 344(2-3):261-7. PubMed ID: 9600662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
    Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
    Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
    Wakitani K; Tazaki H; Matsushita M; Iwamura H
    Inflamm Res; 2000 Mar; 49(3):117-22. PubMed ID: 10807499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
    Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
    Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).
    Hashimoto H; Imamura K; Haruta J; Wakitani K
    J Med Chem; 2002 Mar; 45(7):1511-7. PubMed ID: 11906292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
    Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T
    J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
    Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
    Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
    Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries.
    Yamada M; Numaguchi Y; Okumura K; Harada M; Naruse K; Matsui H; Ito T; Hayakawa T
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):256-62. PubMed ID: 11834525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
    Nagahara T; Okano J; Murawaki Y
    Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
    Nishimura G; Yanoma S; Mizuno H; Kawakami K; Tsukuda M
    Jpn J Cancer Res; 1999 Oct; 90(10):1152-62. PubMed ID: 10595745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
    Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2).
    Talley JJ; Bertenshaw SR; Brown DL; Carter JS; Graneto MJ; Koboldt CM; Masferrer JL; Norman BH; Rogier DJ; Zwwifel BS; Seibert K
    Med Res Rev; 1999 May; 19(3):199-208. PubMed ID: 10232649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.
    Li HL; Zhang HW; Chen DD; Zhong L; Ren XD; St-Tu R
    Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers.
    Ikeda Y; Umemura K; Kondo K; Nakashima M; Kobayashi T; Takahashi M
    Br J Clin Pharmacol; 2002 Nov; 54(5):453-62. PubMed ID: 12445023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.